Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 19, 2025
Cirrhotic Cardiomyopathy: Prevalence and Clinical Impact on Liver Cirrhosis OutcomesTakashi Kitagataya, Goki Suda, Takatsugu Tanaka, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 6, 2026
Prevalence and Prognostic Impact of the Coexistence of Cachexia and Sarcopenia in Patients With Chronic Liver DiseasesTakatsugu Tanaka, Goki Suda, Masatsugu Ohara, et al.
Hepatology International|July 6, 2026
Circulating cfDNA CD86 methylation is associated with durable response to atezolizumab-bevacizumab in hepatocellular carcinomaAkimitsu Meno, Masatsugu Ohara, Goki Suda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 22, 2023
Hepatitis C virus eradication by direct-acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low-density lipoprotein cholesterolemia without an increase in body weightYoshimasa Tokuchi, Goki Suda, Naoki Kawagishi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 19, 2023
Recent prevalence and characteristics of patients with hepatitis delta virus in Hokkaido, JapanTakashi Sasaki, Goki Suda, Masatsugu Ohara, et al.
Alimentary Pharmacology & Therapeutics|September 4, 2024
Positivity of high-sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non-HBV-related HCCNaohiro Yasuura, Goki Suda, Masatsugu Ohara, et al.
JHEP Reports : Innovation in Hepatology|April 17, 2025
Serum FGF21 as a predictor of response to atezolizumab and bevacizumab in HCCRisako Kohya, Goki Suda, Masatsugu Ohara, et al.
Pageof 3